pPB_CAG-PE2-P2A-emiRFP670_hPGK-BSD
(Plasmid
#253553)
-
PurposePrime editing in mammalian cells using PE2
-
Depositing Lab
-
Depositing OrganizationChildren's Hospital of Philadelphia
Located in United States of America -
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 253553 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backboneUnspecified
-
Backbone manufacturerVectorBuilder
-
Vector typeMammalian Expression
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namePE2
-
SpeciesSynthetic; Cas9 is from S. pyogenes; M-MLV RT is from the Moloney murine leukemia virus
Cloning Information
- Cloning method Unknown
Resource Information
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2024.09.16.613361 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pPB_CAG-PE2-P2A-emiRFP670_hPGK-BSD was a gift from Ophir Shalem (Addgene plasmid # 253553 ; http://n2t.net/addgene:253553 ; RRID:Addgene_253553) -
For your References section:
High-throughput optimized prime editing mediated endogenous protein tagging for pooled imaging of protein localization. Sanchez HM, Lapidot T, Shalem O. bioRxiv [Preprint]. 2024 Sep 17:2024.09.16.613361. doi: 10.1101/2024.09.16.613361. 10.1101/2024.09.16.613361 PubMed 39345511